In 2000 healthy people aged 10–60, Sinovac serum-free rabies vaccine given in 5-dose Essen or two 4-dose schedules was non-inferior to a licensed vaccine: seroconversion was 100% in all groups at days 14 and 42, with comparable safety.
RCTn = 2,000
Jing et al. Immunogenicity and safety of serum-free rabies vaccine for human use with simulated post-exposure schedules: A randomized, double-blind, active-controlled phase III clinical trial